Commerce Bank acquired a new position in shares of Corteva, Inc. (NYSE:CTVA – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 61,497 shares of the company’s stock, valued at approximately $5,208,000.
Other hedge funds have also modified their holdings of the company. Arbejdsmarkedets Tillaegspension acquired a new position in Corteva during the fourth quarter valued at approximately $23,679,000. Bank of New York Mellon Corp acquired a new stake in Corteva in the second quarter valued at approximately $392,447,000. Leonteq Securities AG acquired a new stake in Corteva during the 4th quarter valued at $2,350,000. Brandes Investment Partners LP increased its position in shares of Corteva by 1.1% during the fourth quarter. Brandes Investment Partners LP now owns 2,312,515 shares of the company’s stock worth $155,009,000 after acquiring an additional 24,985 shares during the last quarter. Finally, Twin Capital Management Inc. increased its holdings in Corteva by 178.9% during the 4th quarter. Twin Capital Management Inc. now owns 25,394 shares of the company’s stock worth $1,702,000 after purchasing an additional 16,288 shares during the last quarter. 81.54% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
CTVA has been the subject of several research analyst reports. Zacks Research downgraded shares of Corteva from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 11th. Weiss Ratings lowered Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, August 3rd. Mizuho lifted their price target on Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a report on Tuesday, July 14th. BNP Paribas Exane upped their price objective on shares of Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $101.00 target price on shares of Corteva in a research report on Monday, August 3rd. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Corteva presently has a consensus rating of “Moderate Buy” and a consensus price target of $91.50.
Corteva Trading Up 0.1%
Corteva stock opened at $81.84 on Monday. The firm has a market capitalization of $54.60 billion, a price-to-earnings ratio of 54.20, a P/E/G ratio of 2.51 and a beta of 0.57. The company has a 50 day moving average price of $82.13 and a 200 day moving average price of $80.26. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $90.97.
Corteva (NYSE:CTVA – Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The firm had revenue of $6.38 billion for the quarter, compared to analyst estimates of $6.60 billion. During the same period in the previous year, the firm earned $2.20 earnings per share. Corteva’s quarterly revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Research analysts forecast that Corteva, Inc. will post 3.72 EPS for the current year.
Corteva Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Tuesday, September 1st. Corteva’s payout ratio is currently 47.68%.
Corteva Company Profile
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Further Reading
- Five stocks we like better than Corteva
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
